date,title,source
Nov-08-18,Stemline Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-08-18,Stemline Therapeutics Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-16-18,Stemline Therapeutics Announces Oral Presentation of SL-701 Phase 2 Data in Second-Line Glioblastoma at the 23rd Annual Meeting of the Society of Neuro-Oncology (SNO),GlobeNewswire
